نتائج البحث - Sanjeev Phatak

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study

    Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coro... حسب Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study

    Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine... حسب Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    A Multicenter, Retrospective Study to Evaluate the Effectiveness and Safety of Imeglimin in Patients with Type 2 Diabetes Mellitus in a Real-World Clinical Setting (INDI-TIMES Study)

    A Multicenter, Retrospective Study to Evaluate the Effectiveness and Safety of Imeglimin in Patients with Type 2 Diabetes Mellitus in a Real-World Clinical Setting (INDI-TIMES Stud... حسب Shehla Shaikh, Surendra K. Sharma, Sanjeev Phatak, Arthur Asirvatham, Supratik Bhattacharyya, Vinay Kumar Dhandhania, Sameer Muchhala, Niddhi Baxi

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Management of metabolic dysfunction–associated steatotic liver disease (<scp>MASLD</scp>)—An expert consensus statement from Indian diabetologists' perspective

    Management of metabolic dysfunction–associated steatotic liver disease (<scp>MASLD</scp>)—An expert consensus statement from Indian diabetologists' perspective حسب A Amir Zargar, Anil Bhansali, Anirban Majumder, Anuj Maheshwari, Arpandev Bhattacharyya, Arundhati Dasgupta, Banshi Saboo, Bipin Sethi, Debmalya Sanyal, Krishna Seshadri, Neeta Rohit Deshpande, Nitin Kapoor, Om Lakhani, Pradeep Talwalkar, Pramila Kalra, Ravi Mehrotra, Rakesh Sahay, Rishi Shukla, S. Kant, Sambit Das, Sanjay Agarwal, Sanjeev Phatak, G. Shanmugasundar, Shashank Joshi, Shehla Shaikh, Aravind Sosale, Soumik Goswami, Sujoy Ghosh, Vijay Panikar, Viswanathan Mohan

    منشور في 2025
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: